GLP-3R
GLP-1 (Glucagon-Like Peptide-1) receptor agonists are metabolic peptides utilized in veterinary research and specialized clinical settings for companion animals. In cats and dogs, these agents mimic endogenous incretin hormones to stimulate glucose-dependent insulin secretion, suppress inappropriate glucagon secretion, and delay gastric emptying [1.1, 1.3]. They are studied in veterinary science for improving insulin sensitivity, managing feline diabetes mellitus, and aiding in weight loss programs for obese canines [1.2, 1.4].
- Promotes glucose-dependent insulin secretion in cats and dogs
- Highly effective at inducing clinical remission in diabetic felines
- Suppresses postprandial glucagon secretion
- Delays gastric emptying to reduce sharp post-meal blood sugar spikes
- Supports body weight reduction in obese companion animals
Dosages must strictly adapt to species and specific formulas. Research and clinical evaluation of long-acting GLP-1 agonists require careful, individualized protocols, often involving subcutaneous administration and monitoring via continuous glucose tracking [1.2, 1.5].
Store the raw lyophilized powder in a tightly sealed container at -20°C for long-term stability. Following reconstitution with sterile water or bacteriostatic saline, store under strict refrigeration between 2°C and 8°C. Do not freeze the reconstituted liquid, and discard any unused solution after 28 days to ensure efficacy.
Every batch, fully traceable.
Download analytical panels and browse related documentation.
HPLC + Mass Spec assay report.
Reconstitution, storage, and shelf life.
Cited studies for this compound.